The Mexico anti-snoring market is expected to grow at more than 6.5% CAGR from 2023 to 2028, driven by rising disposable income of consumers-Bonafide Research
Request for updated version of the report at the same price
Highend report of this product is available
Request for updated version of the report at the same price
Highend report of this product is available
Request for updated version of the report at the same price
Highend report of this product is available
Snoring is a precise sound caused by the shuddering of the muscular palate and the pillar of the oropharyngeal creek during sleep. A person is classified as a habitual snorer if he or she snores loudly at least three times per week. This is commonly associated with obstructive sleep apnea (OSA). Such habitual snorers experience excessive sleepiness during the day and can improve systemic hypertension in people under the age of 50. When snoring goes untreated, it can lead to stroke, sleep apnea, hypertension, atrial fibrillation, coronary artery disease, and other complications. The two main types of treatment options available today are anti-snoring devices and surgery. These two approaches aid in the security of snoring and the development of sleep quality. Moreover, Companies can partner with medical professionals in Mexico to provide comprehensive solutions that address these issues. In addition, Mexico is a lower-middle-income country, and many people may not be able to afford expensive anti-snoring devices. Companies can consider developing affordable solutions that are accessible to a broader segment of the population. According to the Global Obesity Observatory, the prevalence of obesity in Mexico As of 2021, it is estimated that about 75% of adults in Mexico are overweight or obese. This is one of the highest rates of obesity in the world. The high prevalence of obesity in Mexico is a major public health concern, as it increases the risk of many chronic diseases, including heart disease, diabetes, and certain types of cancer.
According to the research report "Mexico Anti-Snoring Market Overview, 2028," published by Bonafide Research, the Mexico Anti-Snoring market is expected to grow at more than 6.5% CAGR from 2023 to 2028. Mexico has a large population of over 130 million people, and many of them likely suffer from snoring. Therefore, there may be a significant opportunity for companies that manufacture and sell anti-snoring devices in Mexico. In the Mexico market, MADs have the largest market share among the various types of anti-snoring and sleep apnea devices. This is due to their effectiveness, ease of use, and comfort for patients. MADs are typically custom-fitted to each patient's mouth by a dentist or sleep specialist. Furthermore, One advantage of MADs is that they are relatively non-invasive compared to other sleep apnea treatments, such as surgery or continuous positive airway pressure (CPAP) therapy. MADs are also portable and easy to use, making them a convenient option for people who travel frequently. EPAP/CPAP is expected to grow at a higher CAGR during the forecast period. This is due to the increasing prevalence of sleep apnea in the region, as well as the growing awareness among patients and healthcare providers about the benefits of EPAP/CPAP therapy. Based on the distribution channel, hospitals have the largest market share for anti-snoring device distribution. A doctor's prescription is required for many anti-snoring devices, and hospitals are well-equipped to provide this service to patients. E-commerce has the highest CAGR for the distribution of anti-snoring devices. Many anti-snoring devices are sold through online retailers such as Amazon, Mercado Libre, and other e-commerce websites. Online retailers can provide a wide reach, and they may be able to offer lower prices due to lower overhead costs.
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleCustomise your report by selecting specific countries or regions
Specify Scope NowOne individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
We offer 10% Free Customization at the time of purchase
Get Free CustomizationWe sent OTP in your email & phone
Check your spam/junk folder as well
We are friendly and approachable, give us a call.
We use cookies to ensure you get the best experience on our website.